Concepedia

Treatment of Active Crohn's Disease With MLN0002, a Humanized Antibody to the α4β7 Integrin

Brian G. Feagan, Gordon R. Greenberg, Gary Wild, Richard N. Fedorak, Pierre Paré, John WD McDonald, Albert Cohen, Alain Bitton, Jeffrey P. Baker, Réjean Dubé,

Clinical Gastroenterology and Hepatology · 2008 · 285 citations · 23 references

DOI

Concepts

References

23

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Stephen B. Hanauer, Brian G. Feagan, Gary R. Lichtenstein et al. · The Lancet · 2002 · 4.2K citations

, , +12

Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent

Joseph Keane, Sharon K. Gershon, Robert P. Wise et al. · New England Journal of Medicine · 2001 · 3.7K citations · Full text

, , +16

Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

William R. Best, Jack M. Becktel, John W. Singleton et al. · PubMed · 1976 · 3.2K citations

, , +15

Development of a Crohn's Disease Activity Index

William R. Best, Jack M. Becktel, John W. Singleton et al. · Gastroenterology · 1976 · 3.2K citations

, , +12

Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial

Jean–Frédéric Colombel, William J. Sandborn, Paul Rutgeerts et al. · Gastroenterology · 2006 · 2.3K citations · Full text

, , +16